Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival

  • Read more about SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival

Photodynamic Therapy for the Treatment of COVID-19

  • Read more about Photodynamic Therapy for the Treatment of COVID-19

CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis

  • Read more about CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis

Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease

  • Read more about Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

  • Read more about Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19

  • Read more about Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19

Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection

  • Read more about Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection

MacroGenics, Inc.

By efain on Thu, 06/04/2020 - 13:36
  • Read more about MacroGenics, Inc.

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

  • Read more about First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

  • Read more about One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 215
  • Page 216
  • Page 217
  • Page 218
  • Current page 219
  • Page 220
  • Page 221
  • Page 222
  • Page 223
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA